Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Who Might Consider BPC-157 and Who Should Avoid It Based on the preclinical data and clinical patterns of use, the patient populations most commonly prescribed BPC-157 for GI indications include: patients with persistent NSAID gastropathy despite PPI therapy, patients with functional GI symptoms attributed to intestinal barrier dysfunction, and patients with inflammatory bowel disease who have not responded adequately to biologic therapy and seek adjunctive options
Hurts so good
BPC-157 begins working at the cellular level, calming inflammation and stimulating blood flow where its needed most
Frequently Asked Questions When you're dealing with something as unsettling as heart palpitations, it's natural to have a lot of questions swirling around
The peptide cost calculator helps compare the total expense of different vial size strategies
